Latest From Biotech Now

ICYMI: Rep. Hatch slams possible Obama move on drug prices

2017Budget

In a hearing held on Thursday to review the Department of Health and Human Services 2017 budget, Senate Finance Committee Chairman Orrin Hatch (R-UT) pressed HHS Secretary Sylvia Burwell on whether or not the Obama Administration is planning to issue an executive order that would allow the government to negotiate drug prices. Read more in the Washington Examiner. Video of Thursday’s hearing can be found on the Senate Finance Committee website.

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Opens Nominations for Award Honoring an Outstanding Woman in Biotech

RF_2014 Pic

The Rosalind Franklin Award is given annually to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. Rosalind Franklin conceived and captured Photograph 51 of the “B” form of DNA in 1952, while at King’s College in London. This photograph, acquired through 100 hours of X-ray exposure from a machine Dr. Franklin herself refined, revealed the structure of DNA.  The discovery of Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Welcomes Seven New Board Members

new-bio-logo

BIO elected seven new members to its Board of Directors, voted upon at this year’s Board Meetings, held this week in New York City. The following individuals were elected to the Health Section Governing Board: Christopher Boerner, President and Head of the U.S. Commercial Business, BMS Mark Alles, President and Chief Operating Officer, Celgene Gary Zieziula, President and Managing Director, EMD Serono Elizabeth Lewis, Chief Counsel and Chief Compliance Officer, Takeda Pharmaceuticals Jean-Christophe Tellier, Chief Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-2016

The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place this earlier this week in New York City at the Waldorf Astoria with more than 1,400 registrants, including over 600 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 6 fireside chats with biopharma CEOs as well as a special guest, New York Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Integrating the Patient Voice: Recap of the 2016 BIO CEO & Investor Conference

CEO2013_115x75_Thumbnail copy

The 2016 BIO CEO & Investor Conference isn’t just for biotech companies and the investment community, the conference featured a strong patient voice and focus on the patient perspective in drug development and drug delivery. Two of the most highly-attended panel discussions were moderated by patient advocates. On Monday, Sue Peschin, President & Chief Executive Officer, Alliance for Aging Research, led a timely panel discussion with clinical researchers and biotech CEOs around the recent positive Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,